Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples